Literature DB >> 6608423

Cross-reactivity of anti-DNA antibodies with proteoglycans.

P Faaber, P J Capel, G P Rijke, G Vierwinden, L B van de Putte, R A Koene.   

Abstract

Ten sera of patients with systemic lupus erythematosus (SLE) were tested in an enzyme linked immunosorbent assay for their ability to react with glycosaminoglycans, constituents of proteoglycans, in relation to their anti-DNA reactivity. The SLE sera reacted with hyaluronic acid and chondroitin sulphate and this reactivity correlated with the anti-DNA activity of these sera. By contrast, sera obtained from patients with other autoimmune diseases or normal sera lacked any of these reactivities. Anti-DNA antibodies purified by affinity chromatography with either oligo dT cellulose or Cibracon blue F3Ga Sepharose reacted with DNA as well as with hyaluronic acid. The cross-reactivity of anti-DNA antibodies could be confirmed by the reaction of a mouse monoclonal anti-DNA antibody with DNA, hyaluronic acid, and chondroitin sulphate. This pattern of cross-reactivities of anti-DNA antibodies suggests that several compounds can function as antigenic targets for these antibodies provided that their structures contain repeating negatively charged groups.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608423      PMCID: PMC1535916     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus.

Authors:  T Koike; H Tomioka; A Kumagai
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

3.  Antibodies to native and denatured deoxyribonucleic acid in systemic lupus erythematosus.

Authors:  R Arana; M Seligmann
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

4.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

5.  Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique.

Authors:  L A Aarden; E R de Groot; T E Feltkamp
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

6.  Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas.

Authors:  Y Shoenfeld; J Rauch; H Massicotte; S K Datta; J André-Schwartz; B D Stollar; R S Schwartz
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

7.  Enzyme immunoassay for antibodies to native DNA. Specificity and quality of antibodies.

Authors:  R B Eaton; G Schnneider; P H Schur
Journal:  Arthritis Rheum       Date:  1983-01

8.  The precipitin reaction between DNA and a serum factor in systemic lupus erythematosus.

Authors:  H R DEICHER; H R HOLMAN; H G KUNKEL
Journal:  J Exp Med       Date:  1959-01-01       Impact factor: 14.307

9.  Anionic sites in the glomerular basement membrane. In vivo and in vitro localization to the laminae rarae by cationic probes.

Authors:  Y S Kanwar; M G Farquhar
Journal:  J Cell Biol       Date:  1979-04       Impact factor: 10.539

10.  Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease.

Authors:  D Koffler; R Carr; V Agnello; R Thoburn; H G Kunkel
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

View more
  42 in total

1.  Inhibiting effect of charged polymers on interaction of human lupus autoantibodies with certain intracellular proteins.

Authors:  A E Kabakov; L N Brovkina; A M Poverenny; L Cebecauer
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

2.  Idiotype usage by polyclonally activated B cells in experimental autoimmunity and infection.

Authors:  M Sutmuller; J J Baelde; M P Madaio; J A Bruijn; E De Heer
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

3.  The expression of acidic ribosomal phosphoproteins on the surface membrane of different tissues in autoimmune and normal mice which are the target molecules for anti-double-stranded DNA antibodies.

Authors:  K H Sun; W T Liu; S J Tang; C Y Tsai; S C Hsieh; T H Wu; S H Han; C L Yu
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

4.  Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients.

Authors:  K Pirner; A Rascu; W Nürnberg; A Rubbert; J R Kalden; B Manger
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

5.  Binding specificity of antiidiotypic autoantibodies to anti-DNA antibodies in humans.

Authors:  T Sasaki; T Muryoi; O Takai; E Tamate; H Saito; K Yoshinaga
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

6.  Generation of monoclonal anti-dermatan sulphate antibodies cross-reacting to calf thymus DNA.

Authors:  K Ohnishi; A Sagawa; T Nakabayashi; A Ohmoto; M Yoshikawa; I Watanabe; M Mukai; I Yasuda; S Nakagawa
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

7.  Anti-dsDNA antibodies cross-react with ribosomal P proteins expressed on the surface of glomerular mesangial cells to exert a cytostatic effect.

Authors:  K H Sun; W T Liu; C Y Tsai; S J Tang; S H Han; C L Yu
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

8.  Murine monoclonal antibodies to DNA. A comparison of MRL/lpr NZB/W and chronically graft-versus-host-diseased mice.

Authors:  K Brinkman; A van Dam; H van den Brink; R M Termaat; J Berden; R Smeenk
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

9.  Antibodies against sulphatide in sera from patients with autoimmune rheumatic diseases.

Authors:  S Aotsuka; M Okawa-Takatsuji; S Uwatoko; R Yokohari; Y Ikeda; G Toda
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

10.  Dermal Fillers: Do's and Dont's.

Authors:  Maya Vedamurthy; Amar Vedamurthy; Kc Nischal
Journal:  J Cutan Aesthet Surg       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.